Kevin M. Flowers
Marshall Gerstein & Borun LLPGeneral
Experience28 yrs
Elite Ratings
DCT
Practice Areas
Chemical Biotech (16 cases)
Biotech (57 cases)
Chemical (4 cases)
Comp. Arch. and Software (1 case)
Software, Security (2 cases)
Ratings
Experience
Grade
Trend
DCT
L4
A
PTAB
--
--
--
CAFC
L1
B
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:25-CV-01107 | Onyx Therap Inc v. Amneal Pharma Of New York LLC | 09/04/25 | Patent Owner | |
| 1:25-CV-00074 | Regeneron Pharma Inc v. Amgen Inc | 07/31/25 | Challenger | |
| 1:25-CV-00500 | Onyx Therap Inc v. Somerset Therap LLC | 04/24/25 | Patent Owner | |
| 1:24-CV-00039 | Regeneron Pharma Inc v. Amgen Inc | 04/16/24 | ||
| 1:24-MD-03103 | In Re: Aflibercept Patent Litigation | 04/11/24 | ||
| 2:24-CV-00264 | Regeneron Pharma Inc v. Amgen Inc | 01/10/24 | Challenger | |
| 2:23-CV-00610 | Acuitas Therapeutics, Inc. v. CureVac SE | 11/13/23 | Patent Owner | |
| 2:23-CV-00222 | CureVac Se v. BioNTech Se | 05/19/23 | Challenger | |
| 1:18-CV-01064 | Amgen Inc v. Hospira Inc | 07/18/18 | ||
| 1:18-CV-00396 | Seong v. Bedra Inc | 01/18/18 | Patent Owner |